Rozumnyi, V. (2026) “Sustained disease control with aflibercept 8 mg: A turning point in the management of exudative retinal disease: Expert consenus”, Ukrainian Journal of Ophthalmology . Odesa, Ukraine, (2), pp. 71–76. doi: 10.31288/Ukr.j.ophthalmol.202627176.